MAD-MT评分:优化远端血管闭塞机械取栓患者选择的工具
本研究基于国际远端和中血管闭塞卒中注册研究(2017-2023年,37个中心),回顾性分析1007例接受药物治疗或血管内取栓的患者,开发了整合临床需求与手术风险的MAD-MT评分。评分显著改变取栓疗效(P交互=0.048):高评分(≥15)患者取栓90天mRS更优(中位3 vs 4,P=0.009),低评分(<15)患者取栓更差(中位2 vs 1,P=0.014)。
要点
- MAD-MT评分范围-8至49,整合临床需求与手术风险。
- 高评分(≥15)患者取栓90天mRS优于药物管理(中位3 vs 4)。
- 低评分(<15)患者取栓90天mRS劣于药物管理(中位2 vs 1)。
核心结论
- MAD-MT评分可识别远端和中血管闭塞中最可能从取栓获益且风险最低的患者。
研究设计与样本
- 回顾性队列分析,使用国际远端和中血管闭塞卒中注册研究(2017-2023年),纳入37个中心的1007例患者(取栓822例,药物管理185例;中位年龄73岁;女性41%)。
主要发现
- 药物管理队列中,较高的NIHSS评分(每点+1)和未接受静脉溶栓(+7)预测不良结局。
- 取栓队列中,年龄较大(25岁以上每15年-1)、无高血压(-2)和无房颤(-2)预测失败/并发症。
- MAD-MT评分显著改变取栓与药物管理的疗效异质性(P交互=0.048)。
- 高评分(≥15;n=293)患者取栓90天mRS优于药物管理(中位3 vs 4;P=0.009)。
- 低评分(<15;n=710)患者取栓90天mRS劣于药物管理(中位2 vs 1;P=0.014)。
关键数值与推荐
- MAD-MT评分范围-8至49,高评分定义为≥15,低评分定义为<15。
- 不良功能结局定义为90天mRS>2。
临床怎么用
- MAD-MT评分可用于远端和中血管闭塞卒中患者取栓决策,高评分(≥15)提示取栓可能获益,低评分(<15)提示药物管理可能更优。
局限性
- 回顾性队列分析,需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular thrombectomy (EVT) for distal and medium vessel occlusion stroke remains uncertain. We aimed to develop a medium and distal mechanical thrombectomy score integrating clinical need and procedural risk to guide patient selection. METHODS: This retrospective cohort analysis used an international distal and medium vessel occlusion stroke registry spanning the study period of 2017 to 2023. Patients with acute distal and medium vessel occlusion stroke who received medical management (MM) or EVT across 37 stroke centers were included, and those with baseline modified Rankin Scale score of ≥3 or those with missing covariable data were excluded. Multivariable logistic regression identified predictors of poor functional outcome (modified Rankin Scale score >2 at 90 days) in the MM cohort and predictors of EVT failure/complications in the EVT cohort. Predictors of poor outcome on MM were assigned positive weights (clinical need); predictors of EVT failure/harm were assigned negative weights (procedural risk). The medium and distal mechanical thrombectomy score summed these weighted points. Interaction analysis assessed the heterogeneity of EVT effect by score. RESULTS: A total of 1217 patients were identified, and 1007 were included (EVT: 822, MM: 185; median age 73 years; 41% female). Higher National Institutes of Health Stroke Scale score (+1 per point) and lack of intravenous thrombolysis (+7) predicted poor MM outcomes. In the EVT cohort, older age (-1 per 15 years above 25), absence of hypertension (-2), and absence of atrial fibrillation (-2) predicted failure/complications. The medium and distal mechanical thrombectomy score (range -8 to 49) significantly modified EVT effect versus MM (Pinteraction=0.048). In high-score patients (≥15; n=293), EVT yielded a better 90-day modified Rankin Scale score than MM (median, 3 versus 4; P=0.009). Conversely, in low-score patients (<15; n=710), EVT yielded a worse modified Rankin Scale score (median, 2 versus 1; P=0.014). CONCLUSIONS: The medium and distal mechanical thrombectomy score is a pragmatic tool that identifies patients with distal and medium vessel occlusion most likely to benefit from EVT while minimizing risk, supporting patient-centered decisions and future trial design.
引用
- Chen H, Lakhani DA, Salim HA, et al. MAD-MT Score: A Tool to Optimize Patient Selection for Mechanical Thrombectomy in Distal Vessel Occlusions. Stroke. 2026. PMID: 42417042. doi:10.1161/STROKEAHA.125.054852
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。